Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018


ShareCast News - New Issues





Beeks seeks trading places on AIM to accelerate growth

(ShareCast News) - Profitable fintech operator Beeks Financial Cloud Group is expecting to raise 7m when it floats on London's AIM junior market at the end of this month.
[13 Nov '17 08:58]

Arqiva and Bakkavor shelve IPO plans

(ShareCast News) - Investors waiting for the 1.5bn initial public offer of Arqiva and the 100m float of Bakkavor will have to wait wait a little bit longer.
[3 Nov '17 07:50]

Saudi Aramco overseas IPO only one 'option', finance minister says

(ShareCast News) - Saudi Aramco's initial public offering may not be happening after all, following comments by state finance minister Mohammed Al-Jadaan in which he said the flotation was only one 'option'.
[27 Oct '17 11:05]

Springfield raises 25m for housing development projects in Scotland

(ShareCast News) - Scottish housebuilder Springfield Properties raised 25m before costs and expenses as it floated on London's AIM.
[16 Oct '17 12:00]

M7 Multi-Let proposes 300m flotation

(ShareCast News) - Newly established closed-ended investment company M7 Multi-Let REIT announced on Tuesday that it intended to raise up to 300m pounds, before expenses, by way of a placing, offer for subscription and an intermediary offer of ordinary shares in the company's capital.
[11 Oct '17 11:31]

Ready meal group Bakkavor eyes IPO

(ShareCast News) - London-based ready meal provider Bakkavor intends to proceed with an initial public offering so it could begin trading on the main market for listed securities of the London Stock Exchange.
[11 Oct '17 11:02]

JD Sports founders said to preparing Footasylum IPO

(ShareCast News) - John Wardle and David Makin, founders of successful British retailer JD Sports, were reportedly gearing up to try and replicate their previous success at the London Stock Exchange by floating streetwear outlet Footasylum.
[5 Oct '17 14:59]

Saudi Aramco IPO remains on track for 2018

(ShareCast News) - Saudi Aramco still plans to make a stock market debut next year, its chief executive confirmed on Thursday.
[5 Oct '17 10:37]

CEO of Hong Kong stock market vows to continue talks with Saudi Aramco

(ShareCast News) - Hong Kong Exchanges & Clearing chief executive Charles Li pledged to continue talks with Saudi Aramco to woo the oil major to its trading venue, particularly now given the bourse's planned IPO investment link with China.
[6 Sep '17 13:11]

Destiny floats on AIM to pursue antibiotic resistance challenge

(ShareCast News) - Destiny Pharma received a warm welcome when it became the second biotech to float in the UK this year, joining London's AIM junior market on Monday after raising 15.3m to develop its products aimed to tackle anti-microbial resistance.
[4 Sep '17 14:11]



Categories: AIM Bulletin, Broker Recommendations, Commodities, Company News, Dealings and Holdings, Economic News, Foreign Exchange, International News, Market Report, New Issues, News and Announcements, Press Round-Up, Risers and Fallers, Small Cap News, Technical Analysis, Tips Round-Up, Week Ahead.


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.